MAPK8 and Cognitive impairment: Administration of exendin‐4—an anti‐diabetic agent—to Tg mice, decreased IRS‐1pSer and activated JNK, resulting in amelioration of behavioural and cognitive deficits (Bomfim et al., 2012).